Linc
Research Linc (LINC.ST) on Bullrun: market cap SEK 3.85B, P/E 11.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLINC.ST
- ExchangeXSTO
- CountrySweden
- SectorFinancial Services
- IndustryAsset Management
- CurrencySEK
- Market capSEK 3.85B
- P/E11.8
- Financial periodQ2 2026
- RevenueSEK 353.00K
- Net incomeSEK 258.10M
- Free cash flow-SEK 60.60M
- Gross margin-700.8%
Valuation Snapshot
latest market cap is SEK 3.85B; P/E is 11.8.
Peer valuation comparison
Latest P/E is 11.82x versus a Financial Services sector median of 13.41x (11.9% below).
Latest P/E is 11.82x versus a Sweden median of 18.18x (35.0% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | n/a | SEK 1.30B | n/a | n/a | n/a | SEK 549.66M | n/a | SEK 4.83B |
| FY2023 | n/a | SEK 619.46M | n/a | n/a | 22.5 | SEK 519.98M | n/a | SEK 3.53B |
| FY2022 | n/a | -SEK 723.34M | n/a | n/a | 10.7 | SEK 600.55M | n/a | SEK 2.91B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-06 | SEK 3.85B | 11.8 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Linc
Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies.
Related stock research
Other Financial Services stocks
Frequently asked questions
What is Linc's market cap?
Linc's market capitalization is SEK 3.85B.
What is Linc's P/E ratio?
Linc's price-to-earnings (P/E) ratio is 11.8.
What does Linc do?
Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies.